KCNJ3: A Potential Drug Target for Heart Failure, Hypertension and Epilepsy

Target Name: KCNJ3

NCBI ID: G3760

KCNJ3

Other Name(s): potassium inwardly-rectifying channel, subfamily J, member 3 | potassium voltage-gated channel subfamily J member 3 | Potassium inwardly rectifying channel subfamily J member 3, transcript variant 1 | G protein-activated inward rectifier potassium channel 1 | G protein-activated inward rectifier potassium channel 1 (isoform 1) | Inward rectifier K(+) channel Kir3.1 | GIRK1 | G protein-activated inward rectifier potassium channel 1 (isoform 2) | KIR3.1 | potassium channel, inwardly rectifying subfamily J member 3 | KCNJ3_HUMAN | potassium inwardly-rectifying channel subfamily J member 3 splice variant 1e | inward rectifier K+ channel KIR3.1 | KGA | Potassium channel, inwardly rectifying subfamily J member 3 | KCNJ3 variant 2 | inward rectifier K(+) channel Kir3.1 | Potassium inwardly-rectifying channel J3 | Potassium inwardly rectifying channel subfamily J member 3, transcript variant 2 | KCNJ3 variant 1 | potassium inwardly rectifying channel subfamily J member 3 | GIRK-1

KCNJ3: A Potential Drug Target for Heart Failure, Hypertension and Epilepsy

KCNJ3, also known as potassium inwardly-rectifying channel subfamily J member 3, is a protein that plays a crucial role in the regulation of intracellular potassium levels. It is a voltage-dependent channel that is expressed in various tissues, including cardiac muscle, skeletal muscles, and the central nervous system. The function of KCNJ3 is to allow the movement of potassium ions into the cell, which is essential for maintaining the resting membrane potential of the cell and regulating various physiological processes that rely on the presence or absence of electrical signals.

Drug Targeting

KCNJ3 has been identified as a potential drug target for various diseases, including heart failure, hypertension, and epilepsy. The ability of KCNJ3 to regulate potassium levels has been shown to contribute to its potential as a therapeutic agent.

Heart Failure

Hypertension, or high blood pressure, is a major risk factor for heart failure, a condition that can lead to the failure of the heart to pump enough blood to meet the body's needs. High levels of potassium in the heart can contribute to the development and progression of heart failure. According to a study published in the journal Circulation Research, inhibiting the activity of KCNJ3 could be a promising strategy for the treatment of heart failure.

Hypertension

Hypertension, or high blood pressure, is a condition that can lead to a range of health problems, including heart disease, stroke, and kidney damage. The exact cause of hypertension is not known, but it is often associated with an imbalance of electrical signals in the heart. According to a study published in the journal Hypertension, KCNJ3 may be a potential drug target for hypertension as it has been shown to regulate potassium levels in the heart.

Epilepsy

Epilepsy is a neurological disorder that is characterized by the absence of normal electrical activity in the brain. The exact cause of epilepsy is not known, but it is often associated with an imbalance of electrical signals in the brain. According to a study published in the journal Epilepsy Research, KCNJ3 may be a potential drug target for epilepsy as it has been shown to regulate potassium levels in the brain.

Conclusion

KCNJ3 is a protein that plays a crucial role in the regulation of intracellular potassium levels. It is a voltage-dependent channel that is expressed in various tissues, including cardiac muscle, skeletal muscles, and the central nervous system. The function of KCNJ3 is to allow the movement of potassium ions into the cell, which is essential for maintaining the resting membrane potential of the cell and regulating various physiological processes that rely on the presence or absence of electrical signals.

KCNJ3 has been identified as a potential drug target for various diseases, including heart failure, hypertension, and epilepsy. The ability of KCNJ3 to regulate potassium levels has been shown to contribute to its potential as a therapeutic agent. Further research is needed to fully understand the role of KCNJ3 in the regulation of potassium levels and to develop effective treatments for these diseases.

Protein Name: Potassium Inwardly Rectifying Channel Subfamily J Member 3

Functions: This potassium channel is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This receptor plays a crucial role in regulating the heartbeat

The "KCNJ3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNJ3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets